Freenome

Senior Information Security Analyst II

Remote

$60,000 – $90,000Compensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
InternshipJob Type
UnknownVisa
Information Security, CybersecurityIndustries

Requirements

Candidates should possess a Bachelor’s degree in Computer Science, Information Security, or a related field, and have at least five years of experience in information security, with a strong understanding of cybersecurity principles and practices. Demonstrated experience with SIEM systems, IDS/IPS, vulnerability assessments, and penetration testing is essential. Knowledge of cloud security environments and compliance standards such as NIST, SOC 2, and GDPR is highly desirable.

Responsibilities

The Senior Information Security Analyst II will be responsible for implementing, maintaining, and monitoring security systems to detect and respond to security incidents, conducting security investigations and performing root cause analysis, managing security events, and providing expertise in securing cloud and office environments. Additionally, the role involves defining and implementing security controls, ensuring compliance with relevant regulations and standards, and performing vulnerability assessments and penetration testing to proactively identify and mitigate risks.

Skills

SIEM
IDS/IPS
Vulnerability Assessments
Penetration Testing
Cloud Security
NIST
SOC 2
GDPR
Security Incident Response
Root Cause Analysis
Security Controls

Freenome

Biotechnology company for early cancer detection

About Freenome

Freenome focuses on improving cancer detection through advanced blood tests. The company uses a multiomics approach, analyzing various biological data types, including genomics and proteomics, to find cancer markers in blood samples. This method allows for non-invasive early detection of cancer, which is crucial for effective treatment. Freenome differentiates itself from competitors by its unique combination of data analysis techniques and its commitment to clinical trials and research collaborations. The company's goal is to enhance cancer diagnostics and make early detection accessible to healthcare providers and patients, ultimately aiming to save lives through timely intervention.

Key Metrics

San Francisco, CaliforniaHeadquarters
2014Year Founded
$1,032.6MTotal Funding
LATE_VCCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Competitive market-based salaries
Annual bonus opportunities
Relocation packages
Medical, dental, & vision coverage
401k
Wellness programs
Equity
PTO

Risks

Employee layoffs may affect morale and innovation efforts.
Integration of Oncimmune Ltd. could divert focus from core projects.
Competitive landscape in cancer detection may impact Freenome's market share.

Differentiation

Freenome uses a unique multiomics approach for early cancer detection.
The company focuses on non-invasive blood tests for cancer screening.
Freenome's platform designs personalized health conditions based on cell-free genome analysis.

Upsides

Recent $254 million funding boosts clinical programs and platform expansion.
Partnership with Walgreens enhances clinical trial diversity and patient recruitment.
PROACT LUNG study positions Freenome as a leader in lung cancer diagnostics.

Land your dream remote job 3x faster with AI